Advanced Medical Solutions Group plc

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, 0A0D.L has a market cap of 34.56B. Regarding current trading prices, AMS.L is priced at $192.80, while 0A0D.L trades at $71.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas 0A0D.L's P/E ratio is 78.75. In terms of profitability, AMS.L's ROE is +0.03%, compared to 0A0D.L's ROE of +0.04%. Regarding short-term risk, AMS.L is more volatile compared to 0A0D.L. This indicates potentially higher risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, 0O5H.IL has a market cap of 18.37B. Regarding current trading prices, AMS.L is priced at $192.80, while 0O5H.IL trades at $50.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas 0O5H.IL's P/E ratio is 17.08. In terms of profitability, AMS.L's ROE is +0.03%, compared to 0O5H.IL's ROE of +0.10%. Regarding short-term risk, AMS.L is more volatile compared to 0O5H.IL. This indicates potentially higher risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, 0I3I.L has a market cap of 16.25B. Regarding current trading prices, AMS.L is priced at $192.80, while 0I3I.L trades at $83.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas 0I3I.L's P/E ratio is 4.40. In terms of profitability, AMS.L's ROE is +0.03%, compared to 0I3I.L's ROE of +0.05%. Regarding short-term risk, AMS.L is more volatile compared to 0I3I.L. This indicates potentially higher risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, CTEC.L has a market cap of 5.25B. Regarding current trading prices, AMS.L is priced at $192.80, while CTEC.L trades at $257.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas CTEC.L's P/E ratio is 36.77. In terms of profitability, AMS.L's ROE is +0.03%, compared to CTEC.L's ROE of +0.09%. Regarding short-term risk, AMS.L is more volatile compared to CTEC.L. This indicates potentially higher risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, 0I8F.L has a market cap of 3.20B. Regarding current trading prices, AMS.L is priced at $192.80, while 0I8F.L trades at $16.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas 0I8F.L's P/E ratio is 9.56. In terms of profitability, AMS.L's ROE is +0.03%, compared to 0I8F.L's ROE of -0.34%. Regarding short-term risk, AMS.L is more volatile compared to 0I8F.L. This indicates potentially higher risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, 0QMV.L has a market cap of 1.97B. Regarding current trading prices, AMS.L is priced at $192.80, while 0QMV.L trades at $124.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas 0QMV.L's P/E ratio is 50.24. In terms of profitability, AMS.L's ROE is +0.03%, compared to 0QMV.L's ROE of +0.19%. Regarding short-term risk, AMS.L is more volatile compared to 0QMV.L. This indicates potentially higher risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, 0HQ1.L has a market cap of 1.24B. Regarding current trading prices, AMS.L is priced at $192.80, while 0HQ1.L trades at $27.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas 0HQ1.L's P/E ratio is 0.92. In terms of profitability, AMS.L's ROE is +0.03%, compared to 0HQ1.L's ROE of -0.08%. Regarding short-term risk, AMS.L is more volatile compared to 0HQ1.L. This indicates potentially higher risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, 0QQM.L has a market cap of 351.25M. Regarding current trading prices, AMS.L is priced at $192.80, while 0QQM.L trades at $147.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas 0QQM.L's P/E ratio is 56.41. In terms of profitability, AMS.L's ROE is +0.03%, compared to 0QQM.L's ROE of +0.14%. Regarding short-term risk, AMS.L is more volatile compared to 0QQM.L. This indicates potentially higher risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, 0NJ5.L has a market cap of 298.80M. Regarding current trading prices, AMS.L is priced at $192.80, while 0NJ5.L trades at $1.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas 0NJ5.L's P/E ratio is 18.37. In terms of profitability, AMS.L's ROE is +0.03%, compared to 0NJ5.L's ROE of +0.02%. Regarding short-term risk, AMS.L is less volatile compared to 0NJ5.L. This indicates potentially lower risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, TSTL.L has a market cap of 188.42M. Regarding current trading prices, AMS.L is priced at $192.80, while TSTL.L trades at $395.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas TSTL.L's P/E ratio is 30.38. In terms of profitability, AMS.L's ROE is +0.03%, compared to TSTL.L's ROE of +0.19%. Regarding short-term risk, AMS.L is less volatile compared to TSTL.L. This indicates potentially lower risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, BVC.L has a market cap of 68.86M. Regarding current trading prices, AMS.L is priced at $192.80, while BVC.L trades at $15.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas BVC.L's P/E ratio is -15.77. In terms of profitability, AMS.L's ROE is +0.03%, compared to BVC.L's ROE of -0.00%. Regarding short-term risk, AMS.L is less volatile compared to BVC.L. This indicates potentially lower risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, SPEC.L has a market cap of 43.01M. Regarding current trading prices, AMS.L is priced at $192.80, while SPEC.L trades at $42.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas SPEC.L's P/E ratio is -8.46. In terms of profitability, AMS.L's ROE is +0.03%, compared to SPEC.L's ROE of -0.05%. Regarding short-term risk, AMS.L is more volatile compared to SPEC.L. This indicates potentially higher risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, CNSL.L has a market cap of 6.07M. Regarding current trading prices, AMS.L is priced at $192.80, while CNSL.L trades at $2.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas CNSL.L's P/E ratio is N/A. In terms of profitability, AMS.L's ROE is +0.03%, compared to CNSL.L's ROE of N/A. Regarding short-term risk, AMS.L is less volatile compared to CNSL.L. This indicates potentially lower risk in terms of short-term price fluctuations for AMS.L.

AMS.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMS.L stands at 413.76M. In comparison, ODX.L has a market cap of 4.94M. Regarding current trading prices, AMS.L is priced at $192.80, while ODX.L trades at $2.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMS.L currently has a P/E ratio of 64.27, whereas ODX.L's P/E ratio is -2.08. In terms of profitability, AMS.L's ROE is +0.03%, compared to ODX.L's ROE of -0.35%. Regarding short-term risk, AMS.L is less volatile compared to ODX.L. This indicates potentially lower risk in terms of short-term price fluctuations for AMS.L.